Literature DB >> 34514754

Endoplasmic reticulum stress is involved in retinal injury induced by repeated transient spikes of intraocular pressure.

Xue Yang1, Xiaowei Yu1, Zhenni Zhao1, Yuqing He1, Jiamin Zhang1, Xiaoqian Su1, Nannan Sun2, Zhigang Fan3,4.   

Abstract

Clinically, a large proportion of glaucoma patients undergo repeated intraocular pressure (IOP) spike (Spike IOP) attacks during their sleep, which may facilitate retinopathy. In this study, we established a mouse model of repeated transient Spike IOP to investigate the direct damage to the retina following Spike IOP attacks, and elucidated the underlying molecular mechanism. We analyzed the changes in the number of retinal ganglion cells (RGCs) via immunofluorescence. Thereafter, we detected retinal cell apoptosis via terminal deoxynucleotidyl transferase deoxyuridine triphosphate (dUTP) nick-end labeling (TUNEL) staining, and performed RNA sequencing (RNA-seq) to reveal the underlying molecular mechanism. Finally, we validated the expression of key molecules in the endoplasmic reticulum (ER) stress pathway using quantitative real-time polymerase chain reaction (qRT-PCR) and western blot analysis. Results revealed a time-dependent RGC loss in Spike IOP, evidenced by a reduction in the number of Brn3a-positive RGCs in experimental eyes following a 7-d continuous treatment with Spike IOP. In addition, TUNEL staining indicated that apoptosis of retinal cells started in the outer nuclear layer (ONL), and then spread to the ganglion cell layer (GCL) with time. RNA-seq analysis revealed that ER stress might be involved in Spike IOP-induced retinal injury. This result was corroborated by western blot, which revealed upregulation of ER stress-related proteins including binding immunoglobulin protein/glucose-regulated protein 78 (BiP/GRP78), phosphorylated inositol-requiring enzyme 1 (p-IRE1), unspliced X-box-binding protein 1 (XBP1-u), spliced X-box-binding protein 1 (XBP1-s), phosphorylated c-Jun N-terminal kinase (p-JNK), C/EBP-homologous protein (CHOP), and B-cell lymphoma 2 (Bcl-2)-associated X protein (Bax). These findings indicate that repeated IOP transients are detrimental to the retina, while ER stress plays an important role in retinal cell apoptosis in this situation. Notably, repeated Spike IOP among glaucoma patients is a crucial factor for progressive retinopathy.

Entities:  

Keywords:  Endoplasmic reticulum (ER) stress; Glaucoma; Intraocular pressure spike (Spike IOP); Neuron apoptosis; Retinal injury

Mesh:

Substances:

Year:  2021        PMID: 34514754      PMCID: PMC8435347          DOI: 10.1631/jzus.B2100053

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  37 in total

1.  Peak intraocular pressure and glaucomatous progression in primary open-angle glaucoma.

Authors:  Anastasios G P Konstas; Luciano Quaranta; Dimitrios G Mikropoulos; Mayssa B Nasr; Andrea Russo; Harris A Jaffee; Jeanette A Stewart; William C Stewart
Journal:  J Ocul Pharmacol Ther       Date:  2011-10-17       Impact factor: 2.671

2.  Neuronal apoptosis, axon damage and synapse loss occur synchronously in acute ocular hypertension.

Authors:  Lan Zhou; Wei Chen; Dongyue Lin; Wenjie Hu; Zhongshu Tang
Journal:  Exp Eye Res       Date:  2018-12-16       Impact factor: 3.467

Review 3.  ER stress and the unfolded protein response in neurodegeneration.

Authors:  Claudio Hetz; Smita Saxena
Journal:  Nat Rev Neurol       Date:  2017-07-21       Impact factor: 42.937

4.  Swelling and loss of photoreceptors in chronic human and experimental glaucomas.

Authors:  T M Nork; J N Ver Hoeve; G L Poulsen; R W Nickells; M D Davis; A J Weber; S H Sarks; H L Lemley; L L Millecchia
Journal:  Arch Ophthalmol       Date:  2000-02

5.  Association between intraocular pressure peaks and progression of visual field loss.

Authors:  R C Zeimer; J T Wilensky; D K Gieser; M A Viana
Journal:  Ophthalmology       Date:  1991-01       Impact factor: 12.079

6.  Evidence of outer retinal changes in glaucoma patients as revealed by ultrahigh-resolution in vivo retinal imaging.

Authors:  Stacey S Choi; Robert J Zawadzki; Michele C Lim; James D Brandt; John L Keltner; Nathan Doble; John S Werner
Journal:  Br J Ophthalmol       Date:  2010-10-17       Impact factor: 4.638

7.  Differential effects of unfolded protein response pathways on axon injury-induced death of retinal ganglion cells.

Authors:  Yang Hu; Kevin K Park; Liu Yang; Xin Wei; Qiang Yang; Kin-Sang Cho; Peter Thielen; Ann-Hwee Lee; Romain Cartoni; Laurie H Glimcher; Dong Feng Chen; Zhigang He
Journal:  Neuron       Date:  2012-02-09       Impact factor: 17.173

8.  Diurnal and nocturnal effects of brimonidine monotherapy on intraocular pressure.

Authors:  John H K Liu; Felipe A Medeiros; J Rigby Slight; Robert N Weinreb
Journal:  Ophthalmology       Date:  2010-07-21       Impact factor: 12.079

9.  Induction of endoplasmic reticulum stress genes, BiP and chop, in genetic and environmental models of retinal degeneration.

Authors:  Heike Kroeger; Carissa Messah; Kelly Ahern; Jason Gee; Victory Joseph; Michael T Matthes; Douglas Yasumura; Marina S Gorbatyuk; Wei-Chieh Chiang; Matthew M LaVail; Jonathan H Lin
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-11-09       Impact factor: 4.799

10.  Increased ER Stress After Experimental Ischemic Optic Neuropathy and Improved RGC and Oligodendrocyte Survival After Treatment With Chemical Chaperon.

Authors:  Varun Kumar; Louise Alessandra Mesentier-Louro; Angela Jinsook Oh; Kathleen Heng; Mohammad Ali Shariati; Haoliang Huang; Yang Hu; Yaping Joyce Liao
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-05-01       Impact factor: 4.799

View more
  1 in total

1.  Romidepsin (FK228) improves the survival of allogeneic skin grafts through downregulating the production of donor-specific antibody via suppressing the IRE1α-XBP1 pathway.

Authors:  Yuliang Guo; Siyu Song; Xiaoxiao DU; Li Tian; Man Zhang; Hongmin Zhou; Zhonghua Klaus Chen; Sheng Chang
Journal:  J Zhejiang Univ Sci B       Date:  2022-05-15       Impact factor: 5.552

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.